Station 3A lymph node dissection does not improve long‐term survival in right‐side operable non‐small‐cell lung cancer patients: A propensity score matching study

MLA

Mu‐Zi Yang, et al. “Station 3A Lymph Node Dissection Does Not Improve Long‐term Survival in Right‐side Operable Non‐small‐cell Lung Cancer Patients: A Propensity Score Matching Study.” Thoracic Cancer, vol. 13, no. 15, Aug. 2022, pp. 2106–16. EBSCOhost, https://doi.org/10.1111/1759-7714.14456.

APA

Mu‐Zi Yang, Zi‐Hui Tan, Ji‐Bin Li, Hao Long, Jian‐Hua Fu, Lan‐Jun Zhang, Peng Lin, Xue Hou, & Hao‐Xian Yang. (2022). Station 3A lymph node dissection does not improve long‐term survival in right‐side operable non‐small‐cell lung cancer patients: A propensity score matching study. Thoracic Cancer, 13(15), 2106–2116. https://doi.org/10.1111/1759-7714.14456

Chicago

Mu‐Zi Yang, Zi‐Hui Tan, Ji‐Bin Li, Hao Long, Jian‐Hua Fu, Lan‐Jun Zhang, Peng Lin, Xue Hou, and Hao‐Xian Yang. 2022. “Station 3A Lymph Node Dissection Does Not Improve Long‐term Survival in Right‐side Operable Non‐small‐cell Lung Cancer Patients: A Propensity Score Matching Study.” Thoracic Cancer 13 (15): 2106–16. doi:10.1111/1759-7714.14456.